Hi, what are you looking for?
In the first substitution study to track individual use over time, researchers found stark drops in use of opioids and other medications
The firm's valuation is rocketing along with most pot stocks, but uncertainty remains if it can better capitalize on both domestic and international markets
Lead researcher and Tilray VP Philippe Lucas says new data shows why Canada regulating weed on par with alcohol would reduce societal harms
Following comments made at the vice-presidential debate, valuations of 4 big Canadian cannabis firms rose 10% or more